EXELIXIS, INC.
Last · NASDAQ$60.99+1.48 (+2.49%)close · yahoo · 13h ago
Vol 2.73M ≈ 166.53M
MA10MA20MA50
Market cap$15.11B247.8M sh
P/E · TTM19.2fwd 14.3 · eps 3.17
Beta0.47vs S&P 500
Div yield0.00%annual · TTM
52w range
$33.76$61.66
Volume2.7Msession
Issuer
Legal nameEXELIXIS, INC.
HQUnited States (US)
ListingUS EXEL
ISINUS30161Q1040
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0000939767
CIK0000939767
Websitewww.exelixis.com
Employees1,077
AddressExelixis, Inc. 1851 Harbor Bay Parkway 94502, Alameda +650 837 7000
| Revenue | $2.1B |
|---|---|
| Operating income | $499.8M |
| Net income | $422.5M |
| Free cash flow | $551.3M |
| Operating margin | 23.9% |
| Net margin | 20.2% |
| Return on equity | 22.9% |
| Period | TTM 2026-07-03 |
Loading chart…
Upcoming earnings
TUE.27OCT
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.90
Est. revenue
649.7M
Earnings transcripts
- Motley Fool
Exelixis (EXEL) Q2 2026 Earnings Call Transcript
EXELIXIS, INC.
- Issuer webcast
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September
EXELIXIS, INC.
- Issuer webcast
2025 investor day transcript
EXELIXIS, INC.
- Issuer webcast
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in June
EXELIXIS, INC.
Documents
FormReporting forFiledFlags
Showing 5 of 133 filings